European Society of Cardiology Congress 2022
Each year the European Society of Cardiology hosts the largest gathering of cardiologists around the globe in what can only be described as the most important meeting within the field of cardiovascular science. This year in Barcelona the focus was on cardiac imaging and its importance in clinical decision-making, diagnosis, guidance and follow-up and perhaps the ultimate; prevention of cardiac disease. An additional highlight was the release of new ESC Clinical Practice Guidelines, including the 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery (NCS), that focus on the pre-operative CV risk assessment and peri-operative management of patients in whom cardiovascular disease (CVD) is a potential source of complications during NCS.
Prof. Dr. Kristina Haugaa gave two presentations in separate sessions: “Arrhythmogenic mitral valve prolapse: risk stratification” and “Arrhythmogenic mitral valve prolapse: risk stratification”. She was also attending as a panelist.
Assoc. Prof. Dr. Helge Skulstad was a part of the team behind the “2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery” which was published at the congress. He was also part of the expert panel on-site in Barcelona.
Dr. Esra Kaya presented her poster on “Left ventricular mechanical dispersion by speckle tracking echocardiography is a predictor of atrioventricular block after Transcatheter aortic valve implantation”. Concluding with: "With that study we found out that LV mechanical dispersion can be an echocardiographic predictor of AV block after TAVI.”
